1. Improving D‐2‐hydroxyglutarate MR spectroscopic imaging in mutant isocitrate dehydrogenase glioma patients with multiplexed RF‐receive/B 0 ‐shim array coils at 3 T
- Author
-
Philipp Moser, Julia L. Small, Borjan Gagoski, Daniel P. Cahill, Elfar Adalsteinsson, Jacob K. White, Ovidiu C. Andronesi, Wolfgang Bogner, Xianqi Li, Jorg Dietrich, Bijaya Thapa, Andre van der Kouwe, Nicolas S Arango, Tracy T. Batchelor, Bernhard Strasser, and Jason P. Stockmann
- Subjects
Reproducibility ,Accuracy and precision ,Materials science ,Mutant ,Magnetic resonance spectroscopic imaging ,Shim (magnetism) ,medicine.disease ,Multiplexing ,Isocitrate dehydrogenase ,Nuclear magnetic resonance ,Glioma ,medicine ,Molecular Medicine ,Radiology, Nuclear Medicine and imaging ,Spectroscopy - Abstract
MR spectroscopic imaging (MRSI) noninvasively maps the metabolism of human brains. In particular, the imaging of D-2-hydroxyglutarate (2HG) produced by glioma isocitrate dehydrogenase (IDH) mutations has become a key application in neuro-oncology. However, the performance of full field-of-view MRSI is limited by B0 spatial nonuniformity and lipid artifacts from tissues surrounding the brain. Array coils that multiplex RF-receive and B0 -shim electrical currents (AC/DC mixing) over the same conductive loops provide many degrees of freedom to improve B0 uniformity and reduce lipid artifacts. AC/DC coils are highly efficient due to compact design, requiring low shim currents (
- Published
- 2021
- Full Text
- View/download PDF